Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.

Investor Relations

Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London.

ELIQUENT Life Sciences acquires Azzur Consulting strengthening Full-Service Quality & Compliance Capabilities

ELIQUENT Life Sciences

ELIQUENT Life Sciences acquires Azzur Consulting strengthening Full-Service Quality & Compliance Capabilities

+Read Update

ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting

ELIQUENT Life Sciences

ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting

+Read Update

FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility

FairJourney Biologics

FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility

+Read Update

Jan De Witte joins GHO Capital as Operating Partner

GHO Capital Updates

Jan De Witte joins GHO Capital as Operating Partner

+Read Update

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners

Avid Bioservices

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners

+Read Update

GHO Capital Establishes Purpose Advisory Council to Support Delivery of its Better, Faster and More Accessible Healthcare Strategy

GHO Capital Updates

GHO Capital Establishes Purpose Advisory Council to Support Delivery of its Better, Faster and More Accessible Healthcare Strategy

+Read Update

GHO Capital Celebrates 10-Year Anniversary as Europe’s Leading Healthcare Private Equity Group

GHO Capital Updates

GHO Capital Celebrates 10-Year Anniversary as Europe’s Leading Healthcare Private Equity Group

+Read Update

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

Avid Bioservices

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

+Read Update

Insights

From Lab to Market: Opportunities for GHO Capital in the Evolving CDMO Ecosystem

GHO Insights

From Lab to Market: Opportunities for GHO Capital in the Evolving CDMO Ecosystem

+ Read Insight

Leveraging Networks for Operational Excellence: GHO Capital’s Approach

GHO Insights

Leveraging Networks for Operational Excellence: GHO Capital’s Approach

+ Read Insight

GHO Capital & Velocity Clinical Research on building a leading integrated site organisation for clinical trials

GHO Insights

GHO Capital & Velocity Clinical Research on building a leading integrated site organisation for clinical trials

+ Read Insight

Achieving Better, Faster, More Accessible Healthcare

GHO Insights

Achieving Better, Faster, More Accessible Healthcare

+ Read Insight

GHO Capital’s Chief Executive Conference

GHO Insights

GHO Capital’s Chief Executive Conference

+ Read Insight